美国卫生官员以风险为由,劝阻变性青年的青春期阻塞者和荷尔蒙。 US health officials advise against puberty blockers and hormones for transgender youth, citing risks.

美国卫生与公众服务部发布了新的指导方针,建议保健提供者避免使用青春期阻塞器、交叉性激素和手术来治疗患有性残疾的儿童,并列举了重大风险和有限的效益证据。 The US Department of Health and Human Services has issued new guidelines advising healthcare providers to avoid using puberty blockers, cross-sex hormones, and surgeries for children with gender dysphoria, citing significant risks and limited evidence of benefit. 准则建议将心理治疗作为主要治疗选择。 The guidelines recommend psychotherapy as the primary treatment option. 同时,医疗保健和医疗援助服务中心要求提供儿科变性护理的医院提供数据,重点是质量标准和财务细节。 Meanwhile, the Centers for Medicare and Medicaid Services has requested data from hospitals providing pediatric transgender care, focusing on quality standards and financial details.